TLPH
TLPH
NASDAQ · Pharmaceuticals

Talphera Inc

$0.80
+0.07 (+9.08%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +3,181.0% upside
Low Target $16.33
Average Target $26.13
High Target $37.99
Current Price $0.80
Current
$0.80
Target
$26.13
$16.33 $26.13 avg $37.99
Scenario Analysis
Bear Case
$16.33
1,950.5%
Low target
Base Case
$26.13
+3,181.0%
Avg target
Bull Case
$37.99
+4,670.2%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$1.57
-49.3% from high
52-Week Low
$0.38
+109.6% from low
Target vs 52W High
$26.13
+1,564.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%